FDA Approves Highly Anticipated COPD Medication

The Food and Drug Administration has officially approved Breo Ellipta, a much-anticipated new treatment for chronic obstructive pulmonary disease. The inhaled drug was developed by GlaxoSmithKline and Theravance, and is touted as the first once-daily maintenance...

Hospice Being Marketed as a Cost-Cutter for Hospitals

Hospice marketers, exploring possibilities for new revenue to help continue the industry’s remarkable growth, are looking to exploit a provision in the 2010 health care law by persuading hospitals to send Medicare patients into end-of-life hospice care instead...

Newsletter

Stay updated with the latest news and updates.

Get insights, updates, and resources on medical billing, compliance, and revenue optimization—delivered to your inbox.